| 000 | 01134 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513215749.0 | ||
| 264 | 0 | _c20000630 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a1170-7690 | ||
| 024 | 7 |
_a10.2165/00019053-200017030-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEisenstein, E L | |
| 245 | 0 | 0 |
_aEvaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndrome. _h[electronic resource] |
| 260 |
_bPharmacoEconomics _cMar 2000 |
||
| 300 |
_a263-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 |
_aCoronary Disease _xeconomics |
| 650 | 0 | 4 | _aDecision Trees |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aPeterson, E D | |
| 700 | 1 | _aJollis, J G | |
| 700 | 1 | _aTardiff, B E | |
| 700 | 1 | _aCaliff, R M | |
| 700 | 1 | _aKnight, J D | |
| 700 | 1 | _aMark, D B | |
| 773 | 0 |
_tPharmacoEconomics _gvol. 17 _gno. 3 _gp. 263-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00019053-200017030-00004 _zAvailable from publisher's website |
| 999 |
_c10896011 _d10896011 |
||